eGenesis names new CFO and CCO as clinical programs advance

Go back to eGenesis names new CFO and CCO as clinical programs advance
(NASDAQ: EVAX) Delayed: 3.26 +0.05 (1.56%)
Previous Close $3.21    52 Week High
Open $3.18    52 Week Low
Day High $3.31    P/E N/A 
Day Low $3.18    EPS
Volume 24,564